 GERMANTOWN, Md., March 08, 2021 GLOBE NEWSWIRE -- Orgenesis Inc . NASDAQ: ORGS Orgenesis or the Company, a global biotech company working to unlock the full potential of cell and gene therapies CGTs, Dong-a University Hospital in South Korea, and Cure Therapeutics, Inc. Cure Therapeutics, a developer of immuno-oncology and cell and gene therapies to target cancer and infectious diseases, today announced the signing of a collaboration agreement. The teams will align to utilize Orgenesis Mobile Processing Units and Labs OMPULs for point-of-care development of cell and gene therapies and immunotherapies that meet regulatory and governmental approval standards to scale through to commercialization. 